FERRIC CONTRAST, INC.

Medtech · Private

Iron-based MRI contrast agents using macrocyclic ligands to stabilize Fe(III) complexes as alternatives to gadolinium agents

Grants
$1.4M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
4
0 granted · 4 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · STTR Phase I: Relaxivity mechanisms of Fe(III) MRI contrast agents$225,000
Federal grantNational Science Foundation · Phase II · STTR Phase II: Relaxivity mechanisms of Fe(III) MRI contrast agents$899,899
Federal grantDepartment of Health and Human Services · Phase I · MRI contrast agents based on iron as alternatives to gadolinium agents.$305,253
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1026Greenwings Biomedical, Inc.——
1027Spheryx, Inc.—$1.7M
1028Angiotech Pharmaceuticals——
1029FERRIC CONTRAST, INC.——
1030ALIENBYTE Scientific Software Inc——
1031Limber Prosthetics, Inc.—$3.9M
1032CAREBAND, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 4
  • Iron(iii) Macrocyclic Complexes With Mixed Hyroxyl Pendants As Mri Contrast Agentsapplication
  • Iron(iii) Macrocyclic Complexes With Mixed Hyroxyl Pendants As Mri Contrast Agentsapplication
  • Iron(iii) Macrocyclic Complexes With One Or More Tri(hydroxy)butyl Pendant Groups As Mri Contrast Agentsapplication
  • Iron(iii) Macrocyclic Complexes With Mixed Hyroxyl Pendants As Mri Contrast Agentsapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.